22 February 2021
Published in The Lancet Gastroenterology and Hepatology, the Radiotherapy after Oesophageal Cancer Stenting (ROCS) study has become the first prospective trial to show reduced bleeding in tumours treated with radiotherapy in patients with advanced disease.